Progression to Gestational Diabetes Mellitus in Pregnant Women with One Abnormal Value in Repeated Oral Glucose Tolerance Tests
- Author:
Sunyoung KANG
1
;
Min Hyoung KIM
;
Moon Young KIM
;
Joon Seok HONG
;
Soo Heon KWAK
;
Sung Hee CHOI
;
Soo LIM
;
Kyong Soo PARK
;
Hak C JANG
Author Information
- Publication Type:Original Article
- Keywords: Diabetes, gestational; Glucose tolerance test; Pregnancy outcome
- MeSH: Blood Glucose; Body Mass Index; Diabetes, Gestational; Fasting; Female; Gestational Age; Glucose; Glucose Tolerance Test; Humans; Mass Screening; Maternal Age; Parity; Pregnancy; Pregnancy Outcome; Pregnant Women; Retrospective Studies; Weight Gain
- From:Diabetes & Metabolism Journal 2019;43(5):607-614
- CountryRepublic of Korea
- Language:English
- Abstract: BACKGROUND: Women with one abnormal value (OAV) in a 100 g oral glucose tolerance test (OGTT) during pregnancy are reported to have an increased risk of adverse pregnancy outcomes. However, there is limited data about whether women with OAV will progress to gestational diabetes mellitus (GDM) when the OGTT is repeated. METHODS: To identify clinical and metabolic predictors for GDM in women with OAV, we conducted a retrospective study and identified women with OAV in the OGTT done at 24 to 30 weeks gestational age (GA) and repeated the second OGTT between 32 and 34 weeks of GA. RESULTS: Among 137 women with OAV in the initial OGTT, 58 (42.3%) had normal, 40 (29.2%) had OAV and 39 (28.5%) had GDM in the second OGTT. Maternal age, prepregnancy body mass index, weight gain from prepregnancy to the second OGTT, GA at the time of the OGTT, and parity were similar among normal, OAV, and GDM groups. Plasma glucose levels in screening tests were different (151.8±15.7, 155.8±14.6, 162.5±20.3 mg/dL, P<0.05), but fasting, 1-, 2-, and 3-hour glucose levels in the initial OGTT were not. Compared to women with screen negative, women with untreated OAV had a higher frequency of macrosomia. CONCLUSION: We demonstrated that women with OAV in the initial OGTT significantly progressed to GDM in the second OGTT. Clinical parameters predicting progression to GDM were not found. Repeating the OGTT in women with OAV in the initial test may be helpful to detect GDM progression.
